Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- General Virology
-
1. Principles of virology
- Prof. Vincent Racaniello
-
2. The type I interferon system and viruses
- Dr. Adolfo Garcia-Sastre
-
3. Immune responses to viruses
- Prof. Paul Klenerman
- Emerging Pathogens
-
4. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide
- Dr. Marietjie Venter
- Mrs. Orienka Hellferscee
-
5. Emerging respiratory viruses - discoveries between 2001 and 2005
- Prof. Ron Fouchier
-
6. Usage of vaccines and therapeutics in public health emergencies 1
- Prof. Gary Kobinger
-
7. Usage of vaccines and therapeutics in public health emergencies 2
- Prof. Gary Kobinger
-
8. Influenza virus pandemics: past and future
- Prof. Peter Palese
-
9. SARS-CoV and other emerging coronaviruses
- Prof. Ralph Baric
-
10. Dengue, Zika and Chickungunya viruses
- Prof. Ana Fernandez-Sesma
-
11. Paramyxoviruses: biology & pathogenesis
- Prof. Benhur Lee
-
12. Antiviral drugs (non-HIV)
- Prof. Megan Shaw
-
13. Biodefense challenges
- Dr. David Franz
- Important Pathogens and their Diseases
-
14. Natural history and pathogenesis of herpes virus infections
- Prof. Richard Whitley
-
15. Cytomegalovirus biology
- Prof. Domenico Tortorella
-
16. Hepatitis C virus: discovery, cure and protection
- Dr. Matthew Evans
-
17. Fundamentals of HIV biology
- Prof. Viviana Simon
-
18. Measles
- Prof. Diane E. Griffin
-
19. Monkeypox virus, vaccines, and therapeutics
- Prof. Rachel Roper
- New Frontiers
-
22. Viruses as anticancer weapons
- Prof. Roberto Cattaneo
-
23. Novel approaches to diagnosis of viral infections
- Prof. W. Ian Lipkin
-
24. The Global Virus Network: collaboration to address pandemic and regional threats
- Prof. Sten H. Vermund
-
25. Elite controllers of HIV: from discovery to future therapies
- Prof. Bruce Walker
- Archived Lectures *These may not cover the latest advances in the field
-
26. Principles of virology I
- Prof. Richard Condit
-
27. Principles of virology II
- Prof. Richard Condit
-
28. Complex DNA viruses: herpes virus
- Dr. John Blaho
-
29. Adeno-associated viruses (AAV)
- Prof. Kenneth Berns
-
30. Poxviruses: smallpox (variola), vaccinia and monkeypox
- Prof. Paula Traktman
-
31. Can HPV testing be the sole primary cervical screening modality?
- Prof. Jack Cuzick
-
32. From viruses to oncolytics
- Prof. Roberto Cattaneo
-
33. Non HIV antivirals
- Prof. Mary Klotman
-
34. Gastroenteritis viruses
- Prof. Mary Estes
-
35. Biodefense challenges
- Dr. Connie Schmaljohn
-
37. The past, present and future of vaccination
- Prof. Stanley Plotkin
-
38. Filoviruses
- Dr. Christopher Basler
-
39. Bunyaviruses
- Prof. Richard Elliott
-
40. The immunobiology of HIV
- Prof. Norman Letvin
-
41. Hepatitis C and HCV
- Prof. Stanley Lemon
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Cytomegalovirus is a herpesvirus
- Cytomegaloviruses are everywhere
- Historical prospective
- HCMV-associated diseases
- Congenital cytomegalovirus (cCMV) infection
- Congenital CMV
- CMV-associated cancers
- Anti-cytomegalovirus drugs
- Anti-virals in development
- Biologicals targeting CMV
- CMV vaccine development
- Human cytomegalovirus (HCMV)
- HCMV model
- Known entry factors of CMV
- Different mechanisms dependent on cell type
- HCMV life cycle
- CMV latency/reactivation
- The CMV latency-reactivation cycle
- Regulatory factors involved in CMV latency
- CMV is an opportunistic and successful virus
- Immune system-simplified
- MHC class I antigen presentation
- Down-regulation of class I molecules by mutant HCMV
- Other viruses also evade MHC class I
- Natural killer cells
- Cytomegalovirus evasion of NK responses
- CMV factors that limit NK cell activation
- Cellular targets of HCMV miRNA
- CMV genes that mediate cellular functions
- Outstanding topics
Topics Covered
- Introduction to human cytomegalovirus (CMV)
- Diseases associated with CMV
- Therapeutics targeting CMV
- Development of CMV vaccines
- CMV entry factors
- CMV life cycle
- CMV latency and reactivation cycle
- CMV immune evasion strategies including evasion of NK cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Tortorella, D. (2020, April 29). Cytomegalovirus biology [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ATTX3152.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Domenico Tortorella.
I'm a professor in the Department of Microbiology at
the Icahn School of Medicine at Mount Sinai in New York City.
Today, I'm going to discuss some of the highlights of the importance of cytomegalovirus and cytomegalovirus entry.
0:17
The outline of the presentation will include an introduction to herpes viruses,
cytomegalovirus prevalence and disease,
current anti-viral agents and some vaccine trials.
Basically, the importance of,
and for you to recognize the complication of, the CMV life-cycle;
and one aspect is viral entry,
viral latency and one important aspect of the virus is its ability to
persist in their host and we're going to
discuss the important immune evasion strategies of the virus.
0:50
Cytomegalovirus is a herpes virus, and
herpesviruses are basically in three different categories-
considered Alpha, Beta, and Gamma.
The Alpha herpesviruses consist of
herpes simplex virus 1 and 2 and varicella-zoster virus.
You can see in all cases these are
neurotropic viruses and they have a relatively large genome size.
The Beta herpesviruses, a small category, includes
cytomegalovirus, human herpesvirus 6,
human herpesvirus 7,
and they cause wide tissue tropism,
but they're very species-specific.
Recently, HHV 6 and 7 have been associated with Alzheimer's disease
and a recent publication in Immunity shows
that these viruses can affect multiple cell types as well
as potentially cause different various diseases and we're going to
discuss more about the different aspects of all the different diseases
that is associated with the proliferation of human cytomegalovirus.
Note that human cytomegalovirus is the largest genome,
which is over 230 kilobases and we'll see at
the end how a lot of that genome is dedicated to all viral invasion.
The last group is the Gamma herpesviruses,
they usually infect lymph cells and they're considered lymphotropic.
They're associated with cancer,
and these include the Epstein-Barr virus and the Gamma as well as
the Kaposi's sarcoma herpes virus that was more or less discovered,
caused lots of disease in HIV infected individuals and in all cases,
these are viruses that after a primary infection,
in most cases, they cause permanent latent infection,
which usually means they're latent in different reservoirs
of the host and they reactivate at different times
that are based on immunocompromised or inflammatory responses of the host.